Idera, Merck in TLR deal

IDP granted MRK an exclusive worldwide license to develop and commercialize IDP's preclinical

Read the full 131 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE